Evidence map›Paper›PMID 42003226›Full record

ReviewProtein science : a publication of the Protein Society2026

Proteolytic control of mitochondrial protein translocases.

Lara Kroczek, Thomas Langer

Abstract readReview
In one paragraph

Review in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Proteolytic control of mitochondrial protein translocases.Protein science : a publication of the Protein Society · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lara KroczekDepartment of Mitochondrial Proteostasis, Max Planck Institute for Biology of Ageing, Cologne, Germany.ORCID https://orcid.org/0000-0001-7462-6768
Thomas LangerDepartment of Mitochondrial Proteostasis, Max Planck Institute for Biology of Ageing, Cologne, Germany.

Funding

Deutsche Forschungsgemeinschaft 269925409Max-Planck-Gesellschaft
6 · The paper itself

Abstract

Mitochondria are essential organelles that drive numerous cellular processes, including energy metabolism, ion homeostasis, and programmed cell death. This functional versatility relies on a highly dynamic proteome whose composition is continuously remodeled to meet changing cellular and environmental demands. Central to this remodeling are mitochondrial proteases (termed mitoproteases), which maintain protein quality and regulate mitochondrial function through selective processing and degradation events. Their activity ensures rapid degradation of regulatory proteins and dynamically adjusts components of multiprotein complexes. Among their most critical targets are elements of the mitochondrial protein import machinery. By modulating translocase stability and by processing preproteins during translocation, mitoproteases enable precise control over the organelle's proteome, aligning mitochondrial function with the cell's metabolic state. This review discusses how mitoproteases maintain translocase integrity and dynamically regulate mitochondrial protein import and the mitochondrial proteome.

Indexed as

MitochondriaMitochondrial Membrane Transport ProteinsMitochondrial ProteinsProteolysisAnimalsHumansProtein TransportMitochondrial Membrane Transport ProteinsMitochondrial Proteinsmitochondrial proteasesmitochondrial protein importmitochondrial remodelingprotein quality control

Identifiers

PMID42003226
PMCPMC13092810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.